Reza Beigverdi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Reza Beigverdi has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Fereshteh Jabalameli
Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
11 shared publications- Mohammad Emaneini
Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
11 shared publications - Fereshteh Jabalameli
Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
8 shared publications Mohammad Emaneini
Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
8 shared publicationsMahsa Ghamari
Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3 shared publicationsShahnaz Halimi
Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3 shared publications
Latest Publications
- Open Access
- 5 January 2026
- Vol. 20 (1) , 21-27
Serotype Prevalence of Group B Streptococcus among Pregnant Women in Iran: A Systematic Review and Meta-Analyses from 2007-2022.
Group B Streptococcus (GBS; Streptococcus agalactiae) is a significant cause of invasive disease in newborns, often stemming from recto-vaginal colonization in pregnant women. The GBS capsular polysaccharide is a major virulence factor, and ten distinct serotypes (Ia, Ib, II-IX) have now been identified. Understanding the prevalence of these serotypes in maternal colonization is crucial for vaccine development. This study aims to determine the serotype prevalence of GBS among Iranian pregnant women. A systematic search was conducted in MEDLINE (via PubMed), Embase, Web of Science, and the Iranian Databases (SID and Magiran) for studies published between January 2000 and March 2023. Studies were included if they used standardized methods for GBS detection, including recto-vaginal specimen collection and identification [selective media and molecular detection of GBS-specific gene (dltS and atr)]. Studies using nonstandard methods (e.g., cervical, perianal, perirectal or perineal specimens), or focusing on non-maternal GBS colonization were excluded. Meta-analyses were performed using Comprehensive Meta-Analysis (Biostat V2.2) software to estimate serotype prevalence with 95% confidence intervals (CIs). Of 330 articles identified, 14 studies met the inclusion criteria. The meta-analyses showed that 93.2% (95% CI: 90-95.5) of GBS isolates had identifiable serotypes. The predominant serotype was serotype III [39.6% (95% CI: 31.6-48.2)], followed by serotypes II [16.8% (95% CI: 13.8-20.4)], V [14.1% (95% CI: 11.2-17.6)], VI [12.4 (95% CI: 8.2-18.5)], Ia [11.7% (95 CI: 7.8-17.2)] and Ib [11.2 (95% CI: 6.9-17.6)]. Serotype III is the most common GBS serotype among pregnant women in Iran, followed by serotypes II, V, VI, Ia, and Ib. These findings suggest that a pentavalent vaccine targeting these serotypes could be beneficial for preventing GBS-related complications in Iranian pregnant women. However, further research is needed to evaluate the efficacy and implementation of such a vaccine.
- 5 January 2026
- Vol. 20 (1) , 21-27
Open AccessSerotype Prevalence of Group B Streptococcus among Pregnant Women in Iran: A Systematic Review and Meta-Analyses from 2007-2022.
Group B Streptococcus (GBS; Streptococcus agalactiae) is a significant cause of invasive disease in newborns, often stemming from recto-vaginal colonization in pregnant women. The GBS capsular polysaccharide is a major virulence factor, and ten distinct serotypes (Ia, Ib, II-IX) have now been identified. Understanding the prevalence of these serotypes in maternal colonization is crucial for vaccine development. This study aims to determine the serotype prevalence of GBS among Iranian pregnant women. A systematic search was conducted in MEDLINE (via PubMed), Embase, Web of Science, and the Iranian Databases (SID and Magiran) for studies published between January 2000 and March 2023. Studies were included if they used standardized methods for GBS detection, including recto-vaginal specimen collection and identification [selective media and molecular detection of GBS-specific gene (dltS and atr)]. Studies using nonstandard methods (e.g., cervical, perianal, perirectal or perineal specimens), or focusing on non-maternal GBS colonization were excluded. Meta-analyses were performed using Comprehensive Meta-Analysis (Biostat V2.2) software to estimate serotype prevalence with 95% confidence intervals (CIs). Of 330 articles identified, 14 studies met the inclusion criteria. The meta-analyses showed that 93.2% (95% CI: 90-95.5) of GBS isolates had identifiable serotypes. The predominant serotype was serotype III [39.6% (95% CI: 31.6-48.2)], followed by serotypes II [16.8% (95% CI: 13.8-20.4)], V [14.1% (95% CI: 11.2-17.6)], VI [12.4 (95% CI: 8.2-18.5)], Ia [11.7% (95 CI: 7.8-17.2)] and Ib [11.2 (95% CI: 6.9-17.6)]. Serotype III is the most common GBS serotype among pregnant women in Iran, followed by serotypes II, V, VI, Ia, and Ib. These findings suggest that a pentavalent vaccine targeting these serotypes could be beneficial for preventing GBS-related complications in Iranian pregnant women. However, further research is needed to evaluate the efficacy and implementation of such a vaccine.
- Open Access
- 14 November 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 741
Antimicrobial resistance patterns and molecular characterization of Acinetobacter baumannii isolates in non-COVID-19 patients admitted to intensive care units during the pandemic: a retrospective study at a tertiary hospital in Tehran, Iran
Acinetobacter baumannii is one of the most common causes of healthcare-acquired infections, particularly among the critically ill patients in intensive care units (ICUs). Its multidrug‐resistance (MDR) nature is a major factor contributing to treatment difficulties, and ultimately increased patient mortality. This study aimed to investigate the prevalence, antimicrobial resistance patterns, and molecular characteristics of A. baumannii strains isolated from ICU patients (non-COVID-19) in Tehran, Iran. The infection rate of A. baumannii among ICU patients was 2.25% (75/3340). More than 90% of isolates showed resistance to key antibiotics including imipenem, meropenem, cefotaxime, and ciprofloxacin. Colistin was the most effective drug, with a susceptibility rate of 61.3%. The majority of the isolates (92%) were categorized as extensively drug-resistant (XDR) and harbored multiple antibiotic resistance genes (ARGs). Among carbapenem resistance genes, blaOXA-23-like was the most prevalent, detected in 72% (54/75) of isolates, followed by blaOXA-24-like in 49.3% (37/75). Regarding aminoglycoside resistance, the genes aac(6')-Ib and ant(2')-Ia were identified in 66.6% (50/75) and 32% (24/75) of the isolates, respectively. Genotyping by multiplex PCR revealed that most of isolates (85.3%) belonged to GC2. Furthermore, REP-PCR genotyping identified eight different genotypes, with one dominant genotype accounting for 81% (51/63) of isolates. The present study demonstrates the predominance of XDR A. baumannii strains carrying diverse ARGs in our ICU setting. These findings raise concern, as such strains complicate treatment, limit therapeutic options, and may contribute to poor outcomes in critically ill patients. Mortality was high and appeared more associated with extensive resistance than with comorbidities. The clonal dissemination of these strains further emphasizes the need for robust infection control measures. Implementation of strict infection control measures and robust antibiotic stewardship programs remains essential to limit the spread of these highly resistant pathogens.
- 14 November 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 741
Open AccessAntimicrobial resistance patterns and molecular characterization of Acinetobacter baumannii isolates in non-COVID-19 patients admitted to intensive care units during the pandemic: a retrospective study at a tertiary hospital in Tehran, Iran
Acinetobacter baumannii is one of the most common causes of healthcare-acquired infections, particularly among the critically ill patients in intensive care units (ICUs). Its multidrug‐resistance (MDR) nature is a major factor contributing to treatment difficulties, and ultimately increased patient mortality. This study aimed to investigate the prevalence, antimicrobial resistance patterns, and molecular characteristics of A. baumannii strains isolated from ICU patients (non-COVID-19) in Tehran, Iran. The infection rate of A. baumannii among ICU patients was 2.25% (75/3340). More than 90% of isolates showed resistance to key antibiotics including imipenem, meropenem, cefotaxime, and ciprofloxacin. Colistin was the most effective drug, with a susceptibility rate of 61.3%. The majority of the isolates (92%) were categorized as extensively drug-resistant (XDR) and harbored multiple antibiotic resistance genes (ARGs). Among carbapenem resistance genes, blaOXA-23-like was the most prevalent, detected in 72% (54/75) of isolates, followed by blaOXA-24-like in 49.3% (37/75). Regarding aminoglycoside resistance, the genes aac(6')-Ib and ant(2')-Ia were identified in 66.6% (50/75) and 32% (24/75) of the isolates, respectively. Genotyping by multiplex PCR revealed that most of isolates (85.3%) belonged to GC2. Furthermore, REP-PCR genotyping identified eight different genotypes, with one dominant genotype accounting for 81% (51/63) of isolates. The present study demonstrates the predominance of XDR A. baumannii strains carrying diverse ARGs in our ICU setting. These findings raise concern, as such strains complicate treatment, limit therapeutic options, and may contribute to poor outcomes in critically ill patients. Mortality was high and appeared more associated with extensive resistance than with comorbidities. The clonal dissemination of these strains further emphasizes the need for robust infection control measures. Implementation of strict infection control measures and robust antibiotic stewardship programs remains essential to limit the spread of these highly resistant pathogens.
- 5 February 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-13
Prevalence and characteristics of ST131-O16 and ST131-O25b clones among extended-spectrum β-lactamase-producing Escherichia coli isolates causing bloodstream infection in Iran
Background The multidrug-resistant clone identified as Escherichia coli sequence type 131 (E. coli ST131) has spread worldwide. The current study is one of the first comprehensive investigations to ascertain the prevalence of ST131 and molecularly characterize the ST131-O25b and ST131-O16 subgroups causing bloodstream infections in Iran. Methods and results To this end, 119 consecutive, non-repetitive E. coli clinical strains were isolated from blood samples of patients with septicemia in different hospital wards for one year in Tehran. The isolates were provided by the laboratories of tertiary hospitals affiliated with Tehran University of Medical Sciences. The disk diffusion method was used to investigate the sensitivity of bacteria to antibiotics. All phylogroup B2 isolates were screened for E. coli ST131 status using a triplex PCR assay that combines the identification of ST131-O25b and -O16 clades. The seven putative virulence factor genes (kpmstII, fimH, afa A, iroN, Sat, ibeA, and ompT) and resistance genes (blaCTX−M−15, blaOXA−48, and blaCMY) were detected by PCR in E. coli ST131 isolates. Conclusions The highest incidence of antibiotic resistance among 74/119 (62.18%) extended-spectrum β-lactamases-producing E. coli isolates was observed, respectively, against Nalidixic acid (82%), and Aztreonam (75%), followed by Ciprofloxacin (70%). Twenty out of 74 ESBL-producing E. coli isolates were found to be ST131 (27%), with 13 (65%) ST131-O25b and 7 (35%) ST131-O16 clades, respectively. The ST131-O16 isolates had a higher prevalence of resistance to Ceftriaxone, Amikacin, Aztreonam, and Cefepime than the -O25b ones. Concerning virulence capacity, our findings demonstrated that kpmstII, fimH, and ompT genes were found in 85%, 65%, and 30% of ST131 isolates, respectively. Our results reinforce the surveillance of E. coli ST131 clone dissemination as a major drug-resistant pathogen and an important new public health threat in Iran. Accumulation of multiple virulence factors, ESBL carriage, and identified antimicrobial resistance patterns of ST131-O25b and ST131-O16 clones indicate a necessity to develop strategies to control the spread of these isolates in both community and hospital settings.
- 5 February 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-13
Prevalence and characteristics of ST131-O16 and ST131-O25b clones among extended-spectrum β-lactamase-producing Escherichia coli isolates causing bloodstream infection in Iran
Background The multidrug-resistant clone identified as Escherichia coli sequence type 131 (E. coli ST131) has spread worldwide. The current study is one of the first comprehensive investigations to ascertain the prevalence of ST131 and molecularly characterize the ST131-O25b and ST131-O16 subgroups causing bloodstream infections in Iran. Methods and results To this end, 119 consecutive, non-repetitive E. coli clinical strains were isolated from blood samples of patients with septicemia in different hospital wards for one year in Tehran. The isolates were provided by the laboratories of tertiary hospitals affiliated with Tehran University of Medical Sciences. The disk diffusion method was used to investigate the sensitivity of bacteria to antibiotics. All phylogroup B2 isolates were screened for E. coli ST131 status using a triplex PCR assay that combines the identification of ST131-O25b and -O16 clades. The seven putative virulence factor genes (kpmstII, fimH, afa A, iroN, Sat, ibeA, and ompT) and resistance genes (blaCTX−M−15, blaOXA−48, and blaCMY) were detected by PCR in E. coli ST131 isolates. Conclusions The highest incidence of antibiotic resistance among 74/119 (62.18%) extended-spectrum β-lactamases-producing E. coli isolates was observed, respectively, against Nalidixic acid (82%), and Aztreonam (75%), followed by Ciprofloxacin (70%). Twenty out of 74 ESBL-producing E. coli isolates were found to be ST131 (27%), with 13 (65%) ST131-O25b and 7 (35%) ST131-O16 clades, respectively. The ST131-O16 isolates had a higher prevalence of resistance to Ceftriaxone, Amikacin, Aztreonam, and Cefepime than the -O25b ones. Concerning virulence capacity, our findings demonstrated that kpmstII, fimH, and ompT genes were found in 85%, 65%, and 30% of ST131 isolates, respectively. Our results reinforce the surveillance of E. coli ST131 clone dissemination as a major drug-resistant pathogen and an important new public health threat in Iran. Accumulation of multiple virulence factors, ESBL carriage, and identified antimicrobial resistance patterns of ST131-O25b and ST131-O16 clones indicate a necessity to develop strategies to control the spread of these isolates in both community and hospital settings.
- Open Access
- 30 January 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1511122
Acinetobacter baumannii infection in critically ill patients with COVID-19 from Tehran, Iran: the prevalence, antimicrobial resistance patterns and molecular characteristics of isolates
Background: The COVID-19 pandemic has led to the excessive use of antimicrobials in critically ill patients. Infections caused by Acinetobacter baumannii have increased significantly both regionally and globally during the COVID-19 pandemic, posing dramatic challenges for intensive care unit (ICU) patients. This study aimed to determine the prevalence, antimicrobial resistance patterns, presence of selected antimicrobial resistance genes, and genetic diversity of A. baumannii isolates obtained from COVID-19 cases admitted to the ICU at the University Hospital in Iran.Materials and methods: This was a cross-sectional and single-center study comprising patients with A. baumannii infections admitted to the ICU with COVID-19 between April and November 2021. The demographic and clinical data of the patients were collected. Antimicrobial susceptibility testing was conducted based on Clinical Laboratory Standards Institute guidelines. This study used PCR and multiplex PCR to investigate antibiotic resistance genes (ARGs) and global clones (GC), respectively. Genetic diversity was investigated by repetitive element sequence-based PCR (REP-PCR).Results: The prevalence of A. baumannii coinfection in COVID-19 cases was 8.1% (43/528). More than 90% (39/43) of A. baumannii isolates were resistant to cefepime, ampicillin-sulbactam, gentamicin, trimethoprim-sulfamethoxazole and amikacin. Furthermore, 44.2% (19/43) of isolates were resistant to colistin. There were 91% (39/43) isolates that were extensively drug-resistant (XDR). The most prevalence carbapenem resistance encoding genes were bla-OXA-23 65.1% (29/43) and blaNDM 41.8% (18/43). The most common aminoglycoside resistance genes were aac(6’)-Ib 65.1% (28/43) and ant(2)-Ia 46.5% (20/43). Isolates from the prominent Global clone GCII comprised 83.7% (36/43) of total isolates. Genetic fingerprinting using REP-PCR revealed that 39 typeable A. baumannii isolates were categorized into 12 distinct genotypes, of which 72% (28/39) of isolates belonged to one genotype.Conclusion: The high prevalence of XDR A. baumannii such as carbapenem and colistin-resistant strains, poses a significant concern for the treatment of COVID-19 patients, heightening the risk of therapeutic failure. The data demonstrate the dissemination of a single A. baumannii clone carrying multiple ARGs within our hospital. Regarding the limited therapeutic options, it is crucial to implement effective prevention and containment policies to curb the spread of these strains.
- 30 January 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 14, 1511122
Open AccessAcinetobacter baumannii infection in critically ill patients with COVID-19 from Tehran, Iran: the prevalence, antimicrobial resistance patterns and molecular characteristics of isolates
Background: The COVID-19 pandemic has led to the excessive use of antimicrobials in critically ill patients. Infections caused by Acinetobacter baumannii have increased significantly both regionally and globally during the COVID-19 pandemic, posing dramatic challenges for intensive care unit (ICU) patients. This study aimed to determine the prevalence, antimicrobial resistance patterns, presence of selected antimicrobial resistance genes, and genetic diversity of A. baumannii isolates obtained from COVID-19 cases admitted to the ICU at the University Hospital in Iran.Materials and methods: This was a cross-sectional and single-center study comprising patients with A. baumannii infections admitted to the ICU with COVID-19 between April and November 2021. The demographic and clinical data of the patients were collected. Antimicrobial susceptibility testing was conducted based on Clinical Laboratory Standards Institute guidelines. This study used PCR and multiplex PCR to investigate antibiotic resistance genes (ARGs) and global clones (GC), respectively. Genetic diversity was investigated by repetitive element sequence-based PCR (REP-PCR).Results: The prevalence of A. baumannii coinfection in COVID-19 cases was 8.1% (43/528). More than 90% (39/43) of A. baumannii isolates were resistant to cefepime, ampicillin-sulbactam, gentamicin, trimethoprim-sulfamethoxazole and amikacin. Furthermore, 44.2% (19/43) of isolates were resistant to colistin. There were 91% (39/43) isolates that were extensively drug-resistant (XDR). The most prevalence carbapenem resistance encoding genes were bla-OXA-23 65.1% (29/43) and blaNDM 41.8% (18/43). The most common aminoglycoside resistance genes were aac(6’)-Ib 65.1% (28/43) and ant(2)-Ia 46.5% (20/43). Isolates from the prominent Global clone GCII comprised 83.7% (36/43) of total isolates. Genetic fingerprinting using REP-PCR revealed that 39 typeable A. baumannii isolates were categorized into 12 distinct genotypes, of which 72% (28/39) of isolates belonged to one genotype.Conclusion: The high prevalence of XDR A. baumannii such as carbapenem and colistin-resistant strains, poses a significant concern for the treatment of COVID-19 patients, heightening the risk of therapeutic failure. The data demonstrate the dissemination of a single A. baumannii clone carrying multiple ARGs within our hospital. Regarding the limited therapeutic options, it is crucial to implement effective prevention and containment policies to curb the spread of these strains.
- Open Access
- 19 July 2024
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1426510
Phylogenetic group, antibiotic resistance, virulence gene, and genetic diversity of Escherichia coli causing bloodstream infections in Iran
Escherichia coli is one of the most important pathogens causing bloodstream infections (BSIs) throughout the world. We sought to characterize the phylogroup classification, major human sequence types (STs), antimicrobial resistance, presence of selected antimicrobial resistance and virulence genes, and genetic diversity of E. coli isolated from patients with BSIs at the University Hospital in Iran. A total of 100 E. coli bloodstream isolates were collected between December 2020 and June 2022. This study used PCR to investigate phylogenetic groups (A, B1, B2, C, D, E, and F), four major STs (ST69, ST73, ST95, and ST131), antibiotic resistance genes (ARGs), virulence-associated genes (VAGs), and pathogenicity islands (PAIs). Antimicrobial susceptibility testing was done by disk diffusion method. Genetic diversity was analyzed by repetitive element sequence-based PCR (REP-PCR). The phylogenetic group B2 (32%) predominated, followed by phylogenetic group E (25%). ST131 (28%) was the most prevalent ST and the majority of these isolates (89.3%) were of serotype O25b. Most of E. coli isolates (75%) were categorized as multidrug resistant (MDR) with high rates of resistance (>55%) to ampicillin, trimethoprim-sulfamethoxazole, ciprofloxacin, cefazolin, and ceftriaxone. The most frequent ARGs were blaTEM (66%), sul1 (57%), and sul2 (51%). The most prevalent VAGs and PAIs were fimH (type 1 fimbriae adhesin; 85%), aer (iucC) (aerobactin; 79%), traT (serum resistance; 77%), iutA (aerobactin siderophore receptor; 69%), and PAI IV536 (75%), respectively. The highest rate of ARGs and VAGs was observed in the ST131 isolates. REP-PCR analysis showed high diversity among the studied isolates. The high prevalence of MDR septicemic E. coli with different types of ARGs, VAGs and genotypes is an extremely worrisome sign of BSIs treatment and poses a major threat for hospitalized patients. Active surveillance, stringent prescribing policies, increasing the awareness of ARGs among clinicians and re-defining the infection control measures are essential to curb the dissemination of these strains.
- 19 July 2024
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 15, 1426510
Open AccessPhylogenetic group, antibiotic resistance, virulence gene, and genetic diversity of Escherichia coli causing bloodstream infections in Iran
Escherichia coli is one of the most important pathogens causing bloodstream infections (BSIs) throughout the world. We sought to characterize the phylogroup classification, major human sequence types (STs), antimicrobial resistance, presence of selected antimicrobial resistance and virulence genes, and genetic diversity of E. coli isolated from patients with BSIs at the University Hospital in Iran. A total of 100 E. coli bloodstream isolates were collected between December 2020 and June 2022. This study used PCR to investigate phylogenetic groups (A, B1, B2, C, D, E, and F), four major STs (ST69, ST73, ST95, and ST131), antibiotic resistance genes (ARGs), virulence-associated genes (VAGs), and pathogenicity islands (PAIs). Antimicrobial susceptibility testing was done by disk diffusion method. Genetic diversity was analyzed by repetitive element sequence-based PCR (REP-PCR). The phylogenetic group B2 (32%) predominated, followed by phylogenetic group E (25%). ST131 (28%) was the most prevalent ST and the majority of these isolates (89.3%) were of serotype O25b. Most of E. coli isolates (75%) were categorized as multidrug resistant (MDR) with high rates of resistance (>55%) to ampicillin, trimethoprim-sulfamethoxazole, ciprofloxacin, cefazolin, and ceftriaxone. The most frequent ARGs were blaTEM (66%), sul1 (57%), and sul2 (51%). The most prevalent VAGs and PAIs were fimH (type 1 fimbriae adhesin; 85%), aer (iucC) (aerobactin; 79%), traT (serum resistance; 77%), iutA (aerobactin siderophore receptor; 69%), and PAI IV536 (75%), respectively. The highest rate of ARGs and VAGs was observed in the ST131 isolates. REP-PCR analysis showed high diversity among the studied isolates. The high prevalence of MDR septicemic E. coli with different types of ARGs, VAGs and genotypes is an extremely worrisome sign of BSIs treatment and poses a major threat for hospitalized patients. Active surveillance, stringent prescribing policies, increasing the awareness of ARGs among clinicians and re-defining the infection control measures are essential to curb the dissemination of these strains.
- Open Access
- 15 April 2024
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 16 (2) , 187-192
Phenotypic and genotypic evaluation of aminoglycoside resistance in Escherichia coli isolated from patients with blood stream infections in Tehran, Iran
Background and Objectives: Escherichia coli is a significant causative agent of bloodstream infections (BSIs). Aminogly- coside antibiotics play a crucial role in treating severe infections such as sepsis and pneumonia. However, resistance to these antibiotics often occurs due to the production of aminoglycoside-modifying enzymes (AMEs). This study was conducted to assess antimicrobial susceptibility patterns against various aminoglycosides and to determine the prevalence of common AME genes in E. coli strains isolated from BSIs. Materials and Methods: Sixty-five E. coli isolates were obtained from blood samples in a referral hospital in Tehran, Iran. The susceptibility patterns of aminoglycosides were determined using disk diffusion method and AMEs genes were investi- gated using PCR assay. Results: Resistance to aminoglycosides was observed in 64.6% (42/65) of the isolates. The most frequent resistance rate was found for kanamycin (44.6%) and gentamicin (38.5%), followed by tobramycin (29.2%) and amikacin (4.6%). The most frequent AME gene was aac(3)-IVa, which detected in 49.2% isolates, followed by aac(6)-Ib (40%), aac(3)-IIa (32.3%), and ant(2)-Ia (30.8%), respectively. Conclusion: Athough the findings of this survey are based on specimens collected from a single hospital, our study shows that the high prevalence of aminoglycoside resistance is primarily attributed to the presence of the aac(3)-Iva, aac(6)-Ib and aac(3)-IIa genes. The low rate of resistance to amikacin makes this antibiotic a good candidate for treatment of BSIs due to E. coli.
- 15 April 2024
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 16 (2) , 187-192
Open AccessPhenotypic and genotypic evaluation of aminoglycoside resistance in Escherichia coli isolated from patients with blood stream infections in Tehran, Iran
Background and Objectives: Escherichia coli is a significant causative agent of bloodstream infections (BSIs). Aminogly- coside antibiotics play a crucial role in treating severe infections such as sepsis and pneumonia. However, resistance to these antibiotics often occurs due to the production of aminoglycoside-modifying enzymes (AMEs). This study was conducted to assess antimicrobial susceptibility patterns against various aminoglycosides and to determine the prevalence of common AME genes in E. coli strains isolated from BSIs. Materials and Methods: Sixty-five E. coli isolates were obtained from blood samples in a referral hospital in Tehran, Iran. The susceptibility patterns of aminoglycosides were determined using disk diffusion method and AMEs genes were investi- gated using PCR assay. Results: Resistance to aminoglycosides was observed in 64.6% (42/65) of the isolates. The most frequent resistance rate was found for kanamycin (44.6%) and gentamicin (38.5%), followed by tobramycin (29.2%) and amikacin (4.6%). The most frequent AME gene was aac(3)-IVa, which detected in 49.2% isolates, followed by aac(6)-Ib (40%), aac(3)-IIa (32.3%), and ant(2)-Ia (30.8%), respectively. Conclusion: Athough the findings of this survey are based on specimens collected from a single hospital, our study shows that the high prevalence of aminoglycoside resistance is primarily attributed to the presence of the aac(3)-Iva, aac(6)-Ib and aac(3)-IIa genes. The low rate of resistance to amikacin makes this antibiotic a good candidate for treatment of BSIs due to E. coli.
- Open Access
- 30 December 2023
- Published by DoNotEdit in Archives of Razi Institute
- Vol. 78 (6) , 1873-1877
Molecular analysis of Enterococcus faecalis isolates collected during a 4-year period
In the present research, we aimed to determine the characteristics of E. faecalis strains collected from an Iranian Children’s Hospital for four years. Sixty-seven E. faecalis isolates with virulence genes detection, variable-number tandem repeat (VNTR), and multiple-locus variable-number tandem repeat analysis (MLVA) typing were investigated. A high frequency of virulence genes belonged to gelatinase (73%) and Enterococcus faecalis (62%). The MLVA of 67 E. faecalis isolates revealed 52 VNTR patterns and 38 MLVA types (MTs). Furthermore, genetic diversities with the majority of the MT1 as a major MT in different Wards of the Children’s Hospital were found.
- 30 December 2023
- Published by DoNotEdit in Archives of Razi Institute
- Vol. 78 (6) , 1873-1877
Open AccessMolecular analysis of Enterococcus faecalis isolates collected during a 4-year period
In the present research, we aimed to determine the characteristics of E. faecalis strains collected from an Iranian Children’s Hospital for four years. Sixty-seven E. faecalis isolates with virulence genes detection, variable-number tandem repeat (VNTR), and multiple-locus variable-number tandem repeat analysis (MLVA) typing were investigated. A high frequency of virulence genes belonged to gelatinase (73%) and Enterococcus faecalis (62%). The MLVA of 67 E. faecalis isolates revealed 52 VNTR patterns and 38 MLVA types (MTs). Furthermore, genetic diversities with the majority of the MT1 as a major MT in different Wards of the Children’s Hospital were found.
- 30 August 2023
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 15 (41) , 48785-48799
HVHC-ESD-Induced Oxygen Vacancies: An Insight into the Phenomena of Interfacial Interactions of Nanostructure Oxygen Vacancy Sites with Oxygen Ion-Containing Organic Compounds
The challenging environmental chemical and microbial pollution has always caused issues for human life. This article investigates the detailed mechanism of photodegradation and antimicrobial activity of oxide semiconductors and realizes the interface phenomena of nanostructures with toxins and bacteria. We demonstrate how oxygen vacancies in nanostructures affect photodegradation and antimicrobial behavior. Additionally, a novel method with a simple, tunable, and cost-effective synthesis of nanostructures for such applications is introduced to resolve environmental issues. The high-voltage, high-current electrical switching discharge (HVHC-ESD) system is a novel method that allows on-the-spot sub-second synthesis of nanostructures on top and in the water for wastewater decontamination. Experiments are done on rhodamine B as a common dye in wastewater to understand its photocatalytic degradation mechanism. Moreover, the antimicrobial mechanism of oxide semiconductors synthesized by the HVHC-ESD method with oxygen vacancies is realized on methicillin- and vancomycin-resistant Staphylococcus aureus strains. The results yield new insights into how oxygen ions in dyes and bacterial walls interact with the surface of ZnO with high oxygen vacancy, which results in breaking of the chemical structure of dyes and bacterial walls. This interaction leads to degradation of organic dyes and bacterial inactivation.
- 30 August 2023
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 15 (41) , 48785-48799
HVHC-ESD-Induced Oxygen Vacancies: An Insight into the Phenomena of Interfacial Interactions of Nanostructure Oxygen Vacancy Sites with Oxygen Ion-Containing Organic Compounds
The challenging environmental chemical and microbial pollution has always caused issues for human life. This article investigates the detailed mechanism of photodegradation and antimicrobial activity of oxide semiconductors and realizes the interface phenomena of nanostructures with toxins and bacteria. We demonstrate how oxygen vacancies in nanostructures affect photodegradation and antimicrobial behavior. Additionally, a novel method with a simple, tunable, and cost-effective synthesis of nanostructures for such applications is introduced to resolve environmental issues. The high-voltage, high-current electrical switching discharge (HVHC-ESD) system is a novel method that allows on-the-spot sub-second synthesis of nanostructures on top and in the water for wastewater decontamination. Experiments are done on rhodamine B as a common dye in wastewater to understand its photocatalytic degradation mechanism. Moreover, the antimicrobial mechanism of oxide semiconductors synthesized by the HVHC-ESD method with oxygen vacancies is realized on methicillin- and vancomycin-resistant Staphylococcus aureus strains. The results yield new insights into how oxygen ions in dyes and bacterial walls interact with the surface of ZnO with high oxygen vacancy, which results in breaking of the chemical structure of dyes and bacterial walls. This interaction leads to degradation of organic dyes and bacterial inactivation.
- Open Access
- 20 July 2023
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 22 (1) , 1-11
Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates
Background: Biofilms play a role in recalcitrance and treatability of bacterial infections, but majority of known antibiotic resistance mechanisms are biofilm-independent. Biofilms of Pseudomonas aeruginosa, especially in cystic fibrosis patients infected with the alginate producing strains in their lungs, are hard to treat. Changes in growth-related bacterial metabolism in biofilm affect their antibiotic recalcitrance which could be considered for new therapies designed based on these changes. In this study, effects of nitrate, arginine, and ferrous were investigated on antibiotic recalcitrance in alginate-encapsulated P. aeruginosa strains isolated from cystic fibrosis patients in the presence of amikacin, tobramycin, and ciprofloxacin. Also, expression of an efflux pump gene, mexY, was analyzed in selected strains in the presence of amikacin and ferrous. Methods: Clinical P. aeruginosa strains were isolated from cystic fibrosis patients and minimum inhibitory concentration of amikacin, tobramycin, and ciprofloxacin was determined against all the strains. For each antibiotic, a susceptible and a resistant or an intermediate-resistant strain were selected, encapsulated into alginate beads, and subjected to minimal biofilm eradication concentration (MBEC) test. After determining MBECs, sub-MBEC concentrations (antibiotics at concentrations one level below the determined MBEC) for each antibiotic were selected and used to study the effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of encapsulated strains. Effects of ferrous and amikacin on expression of the efflux pump gene, mexY, was studied on amikacin sensitive and intermediate-resistant strains. One-way ANOVA and t test were used as the statistical tests. Results: According to the results, the supplements had a dose-related effect on decreasing the number of viable cells; maximal effect was noted with ferrous, as ferrous supplementation significantly increased biofilm susceptibility to both ciprofloxacin and amikacin in all strains, and to tobramycin in a resistant strain. Also, treating an amikacin-intermediate strain with amikacin increased the expression of mexY gene, which has a role in P. aeruginosa antibiotic recalcitrance, while treating the same strain with ferrous and amikacin significantly decreased the expression of mexY gene, which was a promising result. Conclusions: Our results support the possibility of using ferrous and arginine as an adjuvant to enhance the efficacy of conventional antimicrobial therapy of P. aeruginosa infections.
- 20 July 2023
- Published by Springer Nature in Annals of Clinical Microbiology and Antimicrobials
- Vol. 22 (1) , 1-11
Open AccessDetermining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates
Background: Biofilms play a role in recalcitrance and treatability of bacterial infections, but majority of known antibiotic resistance mechanisms are biofilm-independent. Biofilms of Pseudomonas aeruginosa, especially in cystic fibrosis patients infected with the alginate producing strains in their lungs, are hard to treat. Changes in growth-related bacterial metabolism in biofilm affect their antibiotic recalcitrance which could be considered for new therapies designed based on these changes. In this study, effects of nitrate, arginine, and ferrous were investigated on antibiotic recalcitrance in alginate-encapsulated P. aeruginosa strains isolated from cystic fibrosis patients in the presence of amikacin, tobramycin, and ciprofloxacin. Also, expression of an efflux pump gene, mexY, was analyzed in selected strains in the presence of amikacin and ferrous. Methods: Clinical P. aeruginosa strains were isolated from cystic fibrosis patients and minimum inhibitory concentration of amikacin, tobramycin, and ciprofloxacin was determined against all the strains. For each antibiotic, a susceptible and a resistant or an intermediate-resistant strain were selected, encapsulated into alginate beads, and subjected to minimal biofilm eradication concentration (MBEC) test. After determining MBECs, sub-MBEC concentrations (antibiotics at concentrations one level below the determined MBEC) for each antibiotic were selected and used to study the effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of encapsulated strains. Effects of ferrous and amikacin on expression of the efflux pump gene, mexY, was studied on amikacin sensitive and intermediate-resistant strains. One-way ANOVA and t test were used as the statistical tests. Results: According to the results, the supplements had a dose-related effect on decreasing the number of viable cells; maximal effect was noted with ferrous, as ferrous supplementation significantly increased biofilm susceptibility to both ciprofloxacin and amikacin in all strains, and to tobramycin in a resistant strain. Also, treating an amikacin-intermediate strain with amikacin increased the expression of mexY gene, which has a role in P. aeruginosa antibiotic recalcitrance, while treating the same strain with ferrous and amikacin significantly decreased the expression of mexY gene, which was a promising result. Conclusions: Our results support the possibility of using ferrous and arginine as an adjuvant to enhance the efficacy of conventional antimicrobial therapy of P. aeruginosa infections.
- Open Access
- 15 December 2022
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 1049178
Multiplex high-resolution melting assay for simultaneous detection of five key bacterial pathogens in urinary tract infections: A pilot study
The diagnosis of urinary tract infections (UTIs) is usually based on the results of urine culture, but it is time-consuming, labor-intensive and has a low sensitivity. The aim of this study was to develop multiplex high-resolution melting assay (MHRM) for the simultaneous detection of five common bacterial pathogens (Escherichia coli, Klebsiella pneumoniae, Staphylococcus saprophyticus, Enterococcus faecalis, and group B streptococci (GBS)) directly from urine samples. A total of 287 urine specimens were evaluated by HRM assay and the results were compared with the conventional culture method. Five different melt curves generated and differentiated five bacterial pathogens. The detection limit of the MHRM assay was 1.5 × 103 CFU/ml for E. coli and K. pneumoniae and 1.5 × 102 CFU/ml for S. saprophyticus, E. faecalis and GBS. Compared to culture, the specificity of the MHRM assay ranged from 99.3 to 100%, and sensitivity 100% for all test pathogens. The MHRM assay developed in the current study might be functional tool for the diagnosis of UTIs and has the potential for direct detection of the organism in the clinical samples. Additionally, it creates results in less than 5 h, helping clinicians to start treatment with appropriate antimicrobial agents. This method could be a useful supplement to urine culture.
- 15 December 2022
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 1049178
Open AccessMultiplex high-resolution melting assay for simultaneous detection of five key bacterial pathogens in urinary tract infections: A pilot study
The diagnosis of urinary tract infections (UTIs) is usually based on the results of urine culture, but it is time-consuming, labor-intensive and has a low sensitivity. The aim of this study was to develop multiplex high-resolution melting assay (MHRM) for the simultaneous detection of five common bacterial pathogens (Escherichia coli, Klebsiella pneumoniae, Staphylococcus saprophyticus, Enterococcus faecalis, and group B streptococci (GBS)) directly from urine samples. A total of 287 urine specimens were evaluated by HRM assay and the results were compared with the conventional culture method. Five different melt curves generated and differentiated five bacterial pathogens. The detection limit of the MHRM assay was 1.5 × 103 CFU/ml for E. coli and K. pneumoniae and 1.5 × 102 CFU/ml for S. saprophyticus, E. faecalis and GBS. Compared to culture, the specificity of the MHRM assay ranged from 99.3 to 100%, and sensitivity 100% for all test pathogens. The MHRM assay developed in the current study might be functional tool for the diagnosis of UTIs and has the potential for direct detection of the organism in the clinical samples. Additionally, it creates results in less than 5 h, helping clinicians to start treatment with appropriate antimicrobial agents. This method could be a useful supplement to urine culture.